| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.58▲ | 10.58▼ | 10.58▲ | 10.44▲ | 9.97▲ |
| MA10 | 10.59▼ | 10.58▼ | 10.58▲ | 10.11▲ | 9.48▲ |
| MA20 | 10.58▼ | 10.57▲ | 10.54▲ | 9.96▲ | 8.11▲ |
| MA50 | 10.58▼ | 10.51▲ | 10.22▲ | 9.41▲ | 6.49▲ |
| MA100 | 10.58▼ | 10.16▲ | 10.04▲ | 7.90▲ | 6.46▲ |
| MA200 | 10.54▲ | 10.04▲ | 9.99▲ | 6.66▲ | 4.59▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.008▼ | -0.019▼ | 0.045▲ | 0.182▲ |
| RSI | 49.354▼ | 53.697▲ | 58.228▲ | 61.279▲ | 70.235▲ |
| STOCH | 30.556 | 37.770 | 51.224 | 84.054▲ | 62.636 |
| WILL %R | -60.000 | -71.429 | -54.167 | -13.605▲ | -16.007▲ |
| CCI | -76.812 | -45.963 | -3.367 | 132.431▲ | 101.373▲ |
|
Monday, August 03, 2026 01:05 AM
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients ...
|
|
Tuesday, July 07, 2026 05:00 PM
Detailed price information for Candel Therapeutics Inc (CADL-Q) from The Globe and Mail including charting and trades.
|
|
Saturday, July 04, 2026 05:00 PM
Candel Therapeutics, Inc. (NASDAQ:CADL) CEO Paul Peter Tak has recently sold a portion of his company shares, primarily to satisfy ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/08/26 | 10.69 | 10.74 | 10.52 | 10.59 | 800,789 |
| 06/08/26 | 10.47 | 10.7977 | 10.42 | 10.58 | 1,298,231 |
| 05/08/26 | 10.57 | 10.815 | 10.28 | 10.46 | 750,662 |
| 04/08/26 | 10.15 | 10.52 | 10.09 | 10.51 | 1,072,773 |
| 03/08/26 | 9.97 | 10.175 | 9.51 | 10.07 | 879,390 |
| 31/07/26 | 9.95 | 10.13 | 9.80 | 10.01 | 1,117,505 |
| 30/07/26 | 9.51 | 9.95 | 9.38 | 9.87 | 875,603 |
| 29/07/26 | 9.81 | 9.85 | 9.1612 | 9.40 | 1,441,345 |
| 28/07/26 | 9.76 | 10.15 | 9.56 | 9.68 | 1,667,317 |
| 27/07/26 | 9.51 | 10.20 | 9.51 | 9.96 | 1,272,117 |
|
|
||||
|
|
||||
|
|